Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial Condition

Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

Story continues below

On May 10, 2018, Aemetis, Inc. (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2018. Aemetis will also host an earnings review call on May 10, 2018 at 11:00 am Pacific (PT). For details on the call, visit: http://www.aemetis.com/investors/conferencecalls/.

The press release is being furnished as Exhibit 99.1 to this Current Report on Form 8K and is incorporated herein by reference.

This Form 8K and Exhibit 99.1 hereto shall be deemed “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any registration statement of the issuer.

Item 7.01 Regulation FD Material.

On May 10, 2018, the Company issued a news release, posted to its web site at www.aemetis.com, announcing its earnings for the quarter ended March 31, 2018, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT NUMBER DESCRIPTION

Exhibit 99.1Earnings Release dated May 10, 2018


AEMETIS, INC Exhibit
EX-99.1 2 aemetis_ex991l.htm ADDITIONAL EXHIBITS Blueprint   Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected]     Company Investor Relations/ Media Contact: Todd Waltz  (408) 213-0940 [email protected]       Aemetis,…
To view the full exhibit click here

About Aemetis, Inc. (NASDAQ:AMTX)

Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company’s approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.

An ad to help with our costs